ALPMY
7:30 PM
Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026
Presentation / Abstract • Phase 3ESMO 2026 presentations Fri, Oct 23, 2026, 1:30 PMastellas.com
Catalyst Calendar
Tue, Oct 6, 2026
1 updatesWed, Sep 23, 2026
1 updatesThu, Sep 17, 2026
1 updatesWed, Sep 16, 2026
1 updatesALPMY
7:30 PM
Astellas Announces Personnel Change
astellas.com
Mon, Aug 31, 2026
1 updatesThu, Aug 27, 2026
1 updatesMon, Aug 24, 2026
1 updatesALPMY
7:30 PM
Astellas Doses First Patient in Phase 3 Study of ASP2138 in CLDN18.2-postive and HER2-negative locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
Trial Start • Phase 3Trial initiation Tue, Aug 25, 2026astellas.com
Thu, Aug 6, 2026
1 updatesWed, Aug 5, 2026
1 updatesALPMY
2:30 AM
Q1/FY2026 Financial results
astellas.com